Participants’ prior responses to the SARS-Cov-2 spike protein likely influenced their antibody responses to the COVID-19 XBB.1.5 booster vaccination, which included a mixture of anamnestic responses to Wu-1 epitopes and primary responses to XBB.1.5. Here, PROS1 is linked to COVID-19.